In this CNBC “Power Lunch” segment, Tom Hulick, CEO of Strategy Asset Managers, shares several innovative companies he’s recommending to investors. He discusses Broadcom (AVGO) for its standout performance in AI chip development, particularly its partnership with OpenAI to build and deploy custom AI accelerators.
Tom also highlights Eli Lilly (LLY) for its groundbreaking GLP-1 medications that are reshaping diabetes and obesity treatment, and Intuitive Surgical (ISRG) for pioneering robotic-assisted surgical systems that are defining the future of healthcare.
Each of these companies represents the type of innovation and long-term growth opportunities closely followed by Strategy Asset Managers.